AnaptysBio, Inc. (ANAB) vs Alpha Tau Medical Ltd (DRTS)

A side-by-side comparison of AnaptysBio, Inc. and Alpha Tau Medical Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
AnaptysBio, Inc. logo
ANAB
AnaptysBio, Inc.
$1.42B
$47.93HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
Alpha Tau Medical Ltd logo
DRTS
Alpha Tau Medical Ltd
$1.32B
$14.57HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT

Total return — ANAB vs DRTS

growth of $100 · dividends reinvested · last 6y
ANAB +162.4% (+17.4%/yr)DRTS +47.4% (+6.7%/yr)ANAB compounded faster over this window
0100200300400Start $10020222023202420252026$262$147
ANAB DRTS

ANAB vs DRTS: by the numbers

  • •ANAB is the larger company ($1.42B vs $1.32B market cap).
  • •ANAB is profitable (82.37% net margin) while DRTS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricANABDRTS
P/E ratio8.93N/A
P/S ratio5.97N/A
P/B ratio134.0829.88
EV / EBITDA11.45N/A
FCF yield1.27%N/A

Profitability

MetricANABDRTS
Gross margin98.97%0.00%
Operating margin20.42%0.00%
Net margin82.37%0.00%
ROE1849.06%-210.13%
ROIC47.55%-40.47%

Growth (annualized)

MetricANABDRTS
Revenue CAGR (5Y)18.60%N/A
FCF CAGR (5Y)27.41%N/A
Total return CAGR (5Y)21.54%8.59%

Frequently asked

Is ANAB or DRTS more profitable?
ANAB runs the higher net margin — ANAB at 82.37% versus DRTS at 0.00%.
How have ANAB and DRTS total returns compared?
Over the past 5 years, ANAB delivered 21.54% and DRTS delivered 8.59% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANAB analysisFull DRTS analysisInteractive comparison tool

Dig into the metrics

AnaptysBio P/E ratioAnaptysBio ROEAlpha Tau Medical ROEAnaptysBio operating marginAlpha Tau Medical operating marginAnaptysBio revenue growthAlpha Tau Medical revenue growthAnaptysBio free cash flowAlpha Tau Medical free cash flow

AnaptysBio & Alpha Tau Medical appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.